Explore expert insights for regulatory and quality professionals across pharmaceuticals, biotechnology, and medical devices, covering career guidance, industry trends, hiring insights, and regulatory developments.
UpdatedDiscover regulatory, quality & compliance opportunities delivered straight to your inbox.
Showing 1–8 of 8 articles
How the EU Clinical Trials Regulation and the CTIS portal changed clinical trial submissions in Europe, and what it means for regulatory affairs work.
Breakthrough Therapy Designation brings intensive FDA guidance and rolling review, not a lower evidence bar. What it actually changes for regulatory affairs work.
The EU's proposed pharmaceutical legislation overhaul could reshape exclusivity, timelines, and labeling. Here's what it means for regulatory affairs work.
DSCSA's enhanced traceability rules are now active. Here's the regulatory affairs work that followed: guidance tracking and suspect product investigations.
FDA's drug shortage prevention and resilience requirements are pulling regulatory affairs deeper into supply chain risk. Here's what the new hiring niche actually looks like.
Pediatric study requirements in the US and EU are pulling regulatory affairs work in a specialized direction. Here's what that means for hiring and careers.
MHRA's International Recognition Procedure lets the UK lean on trusted overseas regulators to speed up medicine approvals. What it means for regulatory strategy.
A practical explainer on how the EU AI Act layers onto MDR, IVDR, and pharma regulation, and what it means for the day-to-day work of regulatory affairs teams.
